SCHEMBL805502

SCHEMBL805502

CCc1ccnc(C(=O)N(C)C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMYD3 Q9H7B4 1/20 0.48
ALDH1A1 P00352 2/20 0.47
MAPT P10636 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NOS3 P29474 1/20 0.46
NOS1 P29475 1/20 0.46
NOS2 P35228 1/20 0.46
CTSA P10619 2/20 0.42
KDM4E B2RXH2 1/20 0.41
FGFR3 P22607 1/20 0.38
RIOK2 Q9BVS4 1/20 0.38
CNR2 P34972 1/20 0.38
PYGL P06737 1/20 0.37
PYGM P11217 1/20 0.37
PKM P14618 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
PTGS2 P35354 3/20 0.37
LOXL2 Q9Y4K0 1/20 0.36
PTGS1 P23219 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4942782 0.86 RECQL (0.46) SMYD3ALDH1A1MAPTL3MBTL1KDM4E
SCHEMBL17169790 0.85 ALDH1A1 (0.46) SMYD3ALDH1A1MAPTL3MBTL1KDM4E
Hydrochloric Acid SCHEMBL17161694 0.83 ALDH1A1 (0.45) SMYD3ALDH1A1MAPTL3MBTL1CTSA
SCHEMBL14754861 0.83 SMYD3 (0.43) SMYD3ALDH1A1MAPTL3MBTL1NOS3
SCHEMBL12509819 0.83 ALDH1A1 (0.42) SMYD3ALDH1A1MAPTL3MBTL1KDM4E
SCHEMBL24252514 0.82 ALDH1A1 (0.41) ALDH1A1MAPTL3MBTL1KDM4EFGFR3
SCHEMBL221963 0.80 ALDH1A1 (0.55) SMYD3ALDH1A1MAPTL3MBTL1NOS3
SCHEMBL6173009 0.80 SMYD3 (0.51) SMYD3ALDH1A1MAPTL3MBTL1NOS3
SCHEMBL30281240 0.80 ALDH1A1 (0.55) SMYD3ALDH1A1MAPTL3MBTL1NOS3
Hydrochloric Acid SCHEMBL968208 0.79 ALDH1A1 (0.53) SMYD3ALDH1A1MAPTL3MBTL1NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160022685-A1 HETEROCYCLYLAMINES AS PI3K INHIBITORS INCYTE CORPORATION 2016-01-28 US disclosed
US-20130059835-A1 HETEROCYCLYLAMINES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2013-03-07 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160022685-A1 HETEROCYCLYLAMINES AS PI3K INHIBITORS PIK3CA, PIK3CD, PIK3CB SMYD3 1123/4885ALDH1A1 3232/4885MAPT 4386/4885
US-20130059835-A1 HETEROCYCLYLAMINES AS PI3K INHIBITORS PIK3CA, PIK3CD, PIK3CB SMYD3 1123/4885ALDH1A1 3232/4885MAPT 4386/4885
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 SMYD3 2447/4885ALDH1A1 1267/4885MAPT 3149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.